<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01247155</url>
  </required_header>
  <id_info>
    <org_study_id>9151</org_study_id>
    <nct_id>NCT01247155</nct_id>
  </id_info>
  <brief_title>First Postoperative Day Review After Uneventful Phacoemulsification</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veroia General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Veroia General Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this randomized trial was to examine the value of the review on the first&#xD;
      postoperative day after uneventful phacoemulsification cataract surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Best corrected visual acuity</measure>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <condition>Phacoemulsification</condition>
  <condition>Complications</condition>
  <condition>BCVA</condition>
  <arm_group>
    <arm_group_label>first day review</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-first day review</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        291 consecutive patients who underwent uneventful phacoemulsification cataract surgery were&#xD;
        randomized into two groups: i) Next day review (NDR group, n=146) and ii) No next day&#xD;
        review (NNDR group, n=145).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria were the following:&#xD;
&#xD;
        i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost&#xD;
        nucleus, zonule dehiscence and wound leak,&#xD;
&#xD;
        ii) inadequate social support for overnight care at home,&#xD;
&#xD;
        iii) severely limited visual potential in the fellow eye,&#xD;
&#xD;
        iv) uveitis or ocular trauma,&#xD;
&#xD;
        v) severe systemic diseases limiting activity,&#xD;
&#xD;
        vi) patients with learning disability or dementia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>General Hospital of Veroia</name>
      <address>
        <city>Veroia</city>
        <state>Imathia</state>
        <zip>59100</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <study_first_submitted>November 23, 2010</study_first_submitted>
  <study_first_submitted_qc>November 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2010</study_first_posted>
  <last_update_submitted>November 23, 2010</last_update_submitted>
  <last_update_submitted_qc>November 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2010</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

